Cappel et al., 1974 - Google Patents
Characterization of a human acute phase protein found in association with rubella virus infectionCappel et al., 1974
View PDF- Document ID
- 12250246642128665383
- Author
- Cappel R
- Schluederberg A
- Gifford R
- Horstmann D
- Publication year
- Publication venue
- The Journal of Experimental Medicine
External Links
Snippet
A precipitating antigen, rho, was first detected in the blood of persons with rubella and in rubella virus-infected cell culture fluids (1). Partially purified antigens from both sources were examined and shown to have similar properties, although antigen from serum sedimented …
- 241000282414 Homo sapiens 0 title abstract description 39
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/08—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses
- C07K16/10—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses from RNA viruses, e.g. hepatitis E virus
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay
- G01N33/569—Immunoassay; Biospecific binding assay for micro-organisms, e.g. protozoa, bacteria, viruses
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay
- G01N33/576—Immunoassay; Biospecific binding assay for hepatitis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP0061974B1 (en) | New vaccine and therapy against non-a non-b viral hepatitis, and their preparation process | |
| Imai et al. | Demonstration of two distinct antigenic determinants on hepatitis B e antigen by monoclonal antibodies. | |
| Magnius | Characterization of a new antigen-antibody system associated with hepatitis B. | |
| Cohen et al. | Type-common CP-1 antigen of herpes simplex virus is associated with a 59,000-molecular-weight envelope glycoprotein | |
| Para et al. | Immunoglobulin G (Fc)-binding receptors on virions of herpes simplex virus type 1 and transfer of these receptors to the cell surface by infection | |
| Takahashi et al. | Demonstration of hepatitis B e antigen in the core of Dane particles | |
| Schneider et al. | Rabies group-specific ribonucleoprotein antigen and a test system for grouping and typing of rhabdoviruses | |
| Qualtiere et al. | Epstein‐Barr virus‐induced membrane antigens: Immunochemical characterization of triton X‐100 solubilized viral membrane antigens from EBV‐superinfected raji cells | |
| Holland et al. | Subtyping of hepatitis-associated antigen (HB Ag); simplified technique with counterelectrophoresis | |
| Gerin et al. | Biophysical Characterization of the adr Subtype of Hepatitis B Antigen and Preparation of Anti-γ Sera in Rabbits | |
| Raizman et al. | Detection of circulating antigen in acute experimental infections with Toxoplasma gondii | |
| Mathew et al. | IgA antibody, antibody‐dependent cellular cytotoxicity and prognosis in patients with nasopharyngeal carcinoma | |
| Schmidt et al. | Characterization of antibodies produced in natural and experimental coxsackievirus infections | |
| Sundqvist | Frequency and specificity of varicella zoster virus IgM response | |
| Brzosko et al. | Immunoglobulin classes of antibody to hepatitis B core antigen | |
| Sakuma et al. | The characterization of IgG receptor induced by human cytomegalovirus | |
| Suzumura et al. | Induction of glial cell MHC antigen expression in neurotropic coronavirus infections. Characterization of the H-2-inducing soluble factor elaborated by infected brain cells. | |
| Hughes et al. | Isolation and immunizations with hepatitis A viral structural proteins: induction of antiprotein, antiviral, and neutralizing responses | |
| Gold et al. | Characterization of antibodies to the structural polypeptides of HBsAg: evidence for subtype-specific determinants | |
| Cappel et al. | Characterization of a human acute phase protein found in association with rubella virus infection | |
| Njayou et al. | Purification of measles virus by affinity chromatography and by ultracentrifugation: a comparative study | |
| EP0068465B1 (en) | Non-a, non-b hepatitis-associated antibody conjugate, the use thereof and detection reagent | |
| Cripps et al. | Molecular characteristics of IgA in infant saliva | |
| Rosenquist et al. | Characteristics of the 19S and 7S response to bacteriophage ΦX174 in the fowl | |
| Kurstak et al. | Comparative diagnosis of viral diseases |